EUVIMEDEUVIMED entdecken
Übersichtsarbeit

1-Azaadamantanes: Pharmacological Applications and Synthetic Approaches

H Izumi, S Yamagami, S Futamura

Current Medicinal Chemistry-Cardiovascular & Hematological Agents · 2003

DOI: 10.2174/1568016033477478 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Medicinal Chemistry-Cardiovascular & Hematological Agents, 2003. Verfasst von H Izumi und 2 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Advanced Industrial Science and Technology, AIST Tsukuba West, 16-1 Onogawa, Tsukuba, Ibaraki 305-8569, Japan. izumi.h@aist.go.…. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdamantaneAzirinesCholinergic AntagonistsCircular DichroismDrug DesignFarnesyl-Diphosphate FarnesyltransferaseQuantitative Structure-Activity RelationshipSerotonin Agents

Substanzen

AzirinesCholinergic AntagonistsSerotonin AgentsFarnesyl-Diphosphate FarnesyltransferaseAdamantane

Autor:innen und Institutionen

  • National Institute of Advanced Industrial Science and Technology, AIST Tsukuba West, 16-1 Onogawa, Tsukuba, Ibaraki 305-8569, Japan. izumi.h@aist.go.jp

Zitieren

APA

Izumi, H., Yamagami, S., & Futamura, S. (2003). 1-Azaadamantanes: Pharmacological Applications and Synthetic Approaches. Current Medicinal Chemistry-Cardiovascular & Hematological Agents. https://doi.org/10.2174/1568016033477478

Vancouver

Izumi H, Yamagami S, Futamura S. 1-Azaadamantanes: Pharmacological Applications and Synthetic Approaches. Current Medicinal Chemistry-Cardiovascular & Hematological Agents. 2003. doi:10.2174/1568016033477478

BibTeX
@article{Izumi2003,
  author = {Izumi, H and Yamagami, S and Futamura, S},
  title = {1-Azaadamantanes: Pharmacological Applications and Synthetic Approaches},
  journal = {Current Medicinal Chemistry-Cardiovascular & Hematological Agents},
  year = {2003},
  doi = {10.2174/1568016033477478}
}
Kostenlos starten →